Rheumatic fever and its management

British Medical Journal

Volumn 333, Issue 7579, 2006, Pages 1153-1156

  Cilliers, Antoinette M ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BENZATHINE PENICILLIN; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; PENICILLIN V;

ALLELE; BACTERIAL INFECTION; CARDIOVASCULAR RISK; CARDITIS; DOSE RESPONSE; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; GENETIC PREDISPOSITION; HEALTH CARE COST; HEALTH CARE SYSTEM; HEART FAILURE; HEART VALVE REPLACEMENT; HEART VALVE SURGERY; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFECTION CONTROL; MITRAL VALVE DISEASE; MORTALITY; PHARYNGITIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; SEROTYPE; SOCIOECONOMICS; STREPTOCOCCUS GROUP A;

ELECTROCARDIOGRAPHY; FORECASTING; HEART VALVE DISEASES; HUMANS; RHEUMATIC HEART DISEASE;

EID: 33845394809     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39031.420637.BE     Document Type: Review

References (26)

1. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005;5:685-94.
2. World Health Organization. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation, Geneva. WHO. 29 Oct to 1 Nov, 2001. WHO Tech Rep Ser 2001;923. www.who.int/cardiovascular_diseases/resources/trs923/en/
3. Kaplan MH, Bolande R, Rakaita L, Blair J. Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever. N Engl J Med 1964;271:637-45.
4. Martin DR, Voss LM, Walker SJ, Lennon D. Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected. Pediatr Infect Dis J 1994;13:264-9.
5. Shulman T, Stollerman G, Beall B, Dale J, Tanz RR. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United Stales. Clin Infect Dis 2006;42:441-7.
6. Veasy LG, Tan LY, Daly JA, Korgenski K, Miner L, Bale J, et al. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with continuing high incidence of rheumatic fever in Utah. Pediatrics 2004;113:e168-72.
7. Guedez Y, Kotby A, El-Demellawy M, Galal A, Thomson G, Zaher S, et al. HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogenous patients. Circulation 1999;99:2784-90.
8. McDonald M, Currie BJ, Carapetis JR. Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis 2004;4:240-5.
9. Special writing group of the committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever: Jones criteria, 1992 update. JAMA 1992;268:2069-73.
10. Vasan RS, Shrivastava S, Vijayakumar M, Narang R, Lister BC, Narula J. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation 1996;94:73-82.
11. Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome after valve-replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation 1994;89:191-7.
12. Cilliers AM, Manyemba J, Saloojee H. Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst Rev 2003;(2):CD003176.
13. Uziel V, Hashkes PJ, Kassem E, Padeh S, Goldman R, Vollach B. The use of naproxen in the treatment of children with rheumatic fever. J Pediatr 2000;137:269-71.
14. Herdy GVH, Pinto CA, Oliviaes MC, Carvalho EA, Tchou H, Cosendey R, et al. Rheumatic carditis treated with high doses of pulse therapy methylprednisolone. Arq Bras Cardiol 1999;72:601-0.
15. Mortimer EA Jr, Vaisman S, Vigneau A. The effect of penicillin on acute rheumatic fever and valvular heart disease. N Engl J Med 1959;260;101-12.
16. Barlow JB, Marcus RH, Pocock WA, Barlow CW, Essop R, Sareli P. Mechanisms and management of heart failure in active rheumatic carditis. S Afr Med J 1990;78:181-6.
17. Skoularigis J, Sinovich V, Joubert G, Sareli P. Evaluation of the long-term results of mitral valve repair in 254 young patients with rheumatic mitral regurgitation. Circulation 1994;90:167-74.
18. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord 2005;5:11.
19. Zwart S, Rovers MM, de Melker RA, Hoes AW. Penicillin for acute sore throat in children: randomized, double blind trial. BMJ 2003;327:1324-30.
20. Shulman ST. Evaluation of penicillin, cephalosporins and macrolides for therapy of streptococcal pharyngitis. Pediatrics 1996;97:955-9.
21. Lennon DR. The decline of acute rheumatic fever: unrelated to sore throat management? 42nd interscience conference on antimicrobial agents and chemotherapy, San Diego. Sept 2002;G-1481.
22. Manyemba J, Mayosi MB. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev 2002;(3):CD002227.
23. Spinetto H. Recurrences of rheumatic fever in Auckland, 1993-1999 [dissertation for Master of Health Sciences]. Auckland, New Zealand: University of Auckland, 2003.
24. Olive C, Ho M-F, Dyer J, Lincoln D, Barozzi N, Toth I, et al. Immunization with a tetraepitipic lipid core peptide vaccine construct induces broadly protective immune reponses against group A streptococcus. J Infect Dis 2006;193:1666-76.
25. McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, et al. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 2005;41:1114-22.
26. Robertson KA, Volmink JA, Mayosi BM. Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa - the Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme. S Afr Med J 2006;96:242-5.